Knight ADRC Clinical Trials Unit

Accelerating research and equity in Alzheimer’s treatment

Click to see this content

Leading global efforts to develop and test promising therapies for Alzheimer’s disease and related dementias. In collaboration with the Global Alzheimer’s Platform Foundation and over 100 research partners, the unit conducts clinical trials aimed at reducing disease progression, improving patient outcomes and increasing diversity in research participation. With more than 35 years of experience and over 5,400 participants, the center is committed to advancing science and ensuring equitable access to innovative treatments.